Artículos por temáticas
En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.
Tema
Trastornos del movimiento
103 ARTíCULOS , VIENDO DEL 31 AL 45
Projected numbers of people with movement disorders in the years 2030 and 2050.
Bach JP, Ziegler U, Deuschl G, Dodel R, Doblhammer-Reiter G.
Mov Disord. 2011 Oct;26(12):2286-90. doi: 10.1002/mds.23878.
0
0
0
[Movement disorders and neurometabolic diseases].
Grabli D, Auré K, Roze E.
Rev Neurol (Paris). 2011 Feb;167(2):123-34. doi: 10.1016/j.neurol.2010.07.022. Review. French.
0
0
0
Identifying the genetic components underlying the pathophysiology of movement disorders.
Ezquerra M, Compta Y, Marti MJ.
Appl Clin Genet. 2011 Jun 23;4:81-92. doi: 10.2147/TACG.S7333.
0
0
0
Movement disorders: Cerebellum and basal ganglia interaction essential in RDP.
Ray K.
Nat Rev Neurol. 2011 Apr;7(4):188. doi: 10.1038/nrneurol.2011.35. No abstract available.
0
0
0
Hyperkinetic psychogenic movement disorders.
Edwards MJ, Schrag A.
Handb Clin Neurol. 2011;100:719-29. doi: 10.1016/B978-0-444-52014-2.00051-3. Review. No abstract available.
0
0
0
Milestones in magnetic resonance imaging and transcranial sonography of movement disorders.
Berg D, Steinberger JD, Warren Olanow C, Naidich TP, Yousry TA.
Mov Disord. 2011 May;26(6):979-92. doi: 10.1002/mds.23766. Review. Erratum in: Mov Disord. 2011 Jun;26(7):1372.
0
0
0
A prospective series of patients with hyperglycaemia-associated movement disorders.
Cervantes-Arriaga A, Arrambide G, Rodríguez-Violante M.
J Clin Neurosci. 2011 Oct;18(10):1329-32. doi: 10.1016/j.jocn.2011.01.029.
0
0
0
Drug-induced movement disorders and Syndenham's chorea in an antipsychotic-treated young child.
Jadhav S, Coffey BJ.
J Child Adolesc Psychopharmacol. 2011 Oct;21(5):487-90. doi: 10.1089/cap.2011.2157. No abstract available.
0
0
0
SPECT imaging evaluation in movement disorders: far beyond visual assessment.
Badiavas K, Molyvda E, Iakovou I, Tsolaki M, Psarrakos K, Karatzas N.
Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):764-73. doi: 10.1007/s00259-010-1664-1. Review.
0
0
0
[Recognition of movement disorders. So what?].
van Harten PN.
Tijdschr Psychiatr. 2011;53(1):3-5. Dutch. No abstract available.
0
0
0
Di Battista ME, Giustini P, Bernardi S, Stirpe P, Vanacore N, Meco G.
J Neural Transm (Vienna). 2011 Nov;118(11):1609-12. doi: 10.1007/s00702-011-0638-1.
0
0
0
Pavy-Le Traon A, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Shaftman SR, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Stebbins GT, Rascol O.
Mov Disord. 2011 Sep;26(11):1985-92. doi: 10.1002/mds.23742. Review.
0
0
0
[Deep brain stimulation in movement disorders: a Prague-center experience].
Urgosík D, Jech R, Růzicka E, Růzicka F, Liscák R, Vladyka V.
Cas Lek Cesk. 2011;150(4-5):223-8. Czech.
0
0
0
Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis.
Bosco DA, LaVoie MJ, Petsko GA, Ringe D.
Cold Spring Harb Perspect Biol. 2011 Oct 1;3(10):a007500. doi: 10.1101/cshperspect.a007500. Review.
0
0
0
Tardive movement disorders: a practical approach.
Saifee TA, Edwards MJ.
Pract Neurol. 2011 Dec;11(6):341-8. doi: 10.1136/practneurol-2011-000077. Review. No abstract available.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
